Granite Point Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Granite Point Capital Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,500	Closed	-$350K	–	119
2017 Q1	$350K	Hold	3,500	–	–	0.1%	71
2016 Q4	$376K	Sell	3,500 -10,000	-74%	-$1.17M	0.3%	67
2016 Q3	$1.68M	Buy	+13,500	New	+$1.59M	0.66%	28
2015 Q4	$2.18M	Sell	15,300 -4,700	-24%	-$543K	0.33%	21
2015 Q3	$1.8M	Sell	20,000 -9,160	-31%	-$967K	1.23%	15
2015 Q2	$3.36M	Sell	29,160 -10,840	-27%	-$1.14M	0.98%	10
2015 Q1	$3.82M	Hold	40,000	–	–	1.4%	9
2014 Q4	$2.69M	Buy	40,000 +5,000	+14%	+$310K	1.26%	14
2014 Q3	$1.89M	Hold	35,000	–	–	0.94%	18
2014 Q2	$1.56M	Buy	+35,000	New	+$1.43M	1.07%	19

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Granite Point Capital Management's CBPO Position: Q2 2017 in Review

Granite Point Capital Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2017, closing a stake of 3,500 shares — an estimated $350K sold.

Granite Point Capital Management first reported a position in CBPO in Q2 2014 and held it in 10 quarters. The position peaked at $3.82M in Q1 2015. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

Granite Point Capital Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
Granite Point Capital Management sold 3,500 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $350K.
Granite Point Capital Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 10 quarters.
Granite Point Capital Management's China Biologic Products Holdings, Inc. position peaked at $3.82M in Q1 2015.
119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on Granite Point Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.